Researchers have made progress in developing a genetic test that may predict the risk of leukemia relapse. The test, which involves analyzing genetic material such as dna from bone marrow or blood, could help guide treatment for leukemia patients and identify those at greater risk for relapse. The specifics of the test and its application to different types of leukemia, including acute myeloid leukemia and childhood leukemia, are being explored in various studies.